Search Results - "Kelso, E J"

Refine Results
  1. 1

    Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches by Gong, K Z, Song, G, Spiers, J P, Kelso, E J, Zhang, Z G

    “…Despite extensive research and novel treatments, chronic heart failure (CHF) remains a cause of high morbidity and mortality. Mounting evidence suggested that…”
    Get more information
    Journal Article
  2. 2

    Endothelin(A) receptor subtype mediates endothelin-induced contractility in left ventricular cardiomyocytes isolated from rabbit myocardium by Kelso, E J, McDermott, B J, Silke, B, Spiers, J P

    “…Endothelin (ET)-1 is a potent positive inotropic agent, the effects of which are mediated by increases in cytosolic Ca(2+) in the myocardium. The object of…”
    Get more information
    Journal Article
  3. 3

    Inotropic response to endothelin‐1, isoprenaline and calcium in cardiomyocytes isolated from endotoxin treated rats: effects of ethyl‐isothiourea and dexamethasone by Spiers, J P, Kelso, E J, Allen, J D, Silke, B, McDermott, B J

    Published in British journal of pharmacology (01-07-2000)
    “…The contractile effects of endothelin‐1, isoprenaline and extracellular calcium were assessed on ventricular cardiomyocytes isolated from…”
    Get full text
    Journal Article
  4. 4

    Endothelin‐1 mediated inhibition of the acetylcholine‐activated potassium current from rabbit isolated atrial cardiomyocytes by Spiers, J. Paul, Kelso, Elizabeth J., McDermott, Barbara J., Scholfield, C. Norman, Silke, Bernard

    Published in British journal of pharmacology (01-12-1996)
    “…1 Endothelin‐1 is a 21 amino acid peptide with potent inotropic and chronotropic actions in the heart. Relatively little is known about the underlying…”
    Get full text
    Journal Article
  5. 5

    Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes by Kelso, Elizabeth J., McDermott, Barbara J., Silke, Bernard

    Published in British journal of pharmacology (01-12-1993)
    “…1 The contractile effects of the novel cardiotonic agent HN‐10200 (2‐[3‐methoxy‐5‐methylsulphinyl‐2‐thienyl]‐1H‐imidazo‐[4,5‐c]‐pyridine hydrochloride), were…”
    Get full text
    Journal Article
  6. 6

    Involvement of Endothelin (ET)A and ETB Receptors in the Hypertrophic Effects of ET-1 in Rabbit Ventricular Cardiomyocytes by Mullan, Deirdre M, Bell, David, Kelso, Elizabeth J, McDermott, Barbara J

    Published in Journal of cardiovascular pharmacology (01-03-1997)
    “…The question was addressed whether endothelin-1 (ET-1) exerts hypertrophic effects in cardiomyocytes isolated from ventricles of adult rabbits and maintained…”
    Get full text
    Journal Article
  7. 7

    Stimulation of L-type Ca2+ current by the endothelin receptor A-selective antagonist, BQ-123, in ventricular cardiomyocytes isolated from rabbit myocardium by KELSO, E. J, SPIERS, J. P, MCDERMOTT, B. J, SCHOLFIELD, C. N, SILKE, B

    Published in Biochemical pharmacology (15-03-1998)
    “…BQ-123 is extensively used as an antagonist at endothelin (ET) receptors, having selectivity at the ET(A) receptor subtype. In this study, the effects of…”
    Get full text
    Journal Article
  8. 8

    Actions of the novel vasodilator, flosequinan, in isolated ventricular cardiomyocytes by Kelso, E J, McDermott, B J, Silke, B

    Published in Journal of cardiovascular pharmacology (01-03-1995)
    “…Although the potent vasodilating effect of flosequinan is well characterised, the positive inotropic action reported is more varied and less well understood…”
    Get more information
    Journal Article
  9. 9

    Differential effects of phosphodiesterase inhibitors on accumulation of cyclic AMP in isolated ventricular cardiomyocytes by Kelso, Elizabeth J., McDermott, Barbara J., Silke, Bernard

    Published in Biochemical pharmacology (14-02-1995)
    “…The intracellular actions of phosphodiesterase (PDE) inhibitors on the accumulation of cyclic nucleotides were studied in isolated ventricular cardiomyocytes…”
    Get full text
    Journal Article
  10. 10

    Economic evaluation of the use of nadroparin in the treatment of deep-vein thrombosis in Switzerland by Lloyd, A C, Aitken, J A, Hoffmeyer, U K, Kelso, E J, Wakerly, E C, Barber, N D

    Published in The Annals of pharmacotherapy (01-07-1997)
    “…To compare the cost implications, from the payer's perspective, of the use of nadroparin instead of unfractionated heparin in the initial treatment of…”
    Get more information
    Journal Article
  11. 11

    Positive and Negative Contractile Effects of Somatostatin-14 on Rat Ventricular Cardiomyocytes by Murray, Fiona, Bell, David, Kelso, Elizabeth J, Millar, B Cherie, McDermott, Barbara J

    Published in Journal of cardiovascular pharmacology (01-03-2001)
    “…Somatostatin-14 elicits negative inotropic and chronotropic actions in atrial myocardium. Less is known about the effects of somatostatin-14 in ventricular…”
    Get full text
    Journal Article
  12. 12

    Myocardial Expression of the Endothelin System in Endotoxin- Treated Rats by Spiers, James Paul, Dorman, Alastair, Allen, John Desmond, Kelso, Elizabeth Jane, Silke, Bernard, McDermott, Barbara Jean

    Published in Journal of cardiovascular pharmacology (01-08-2001)
    “…Although circulating plasma levels of endothelin (ET)-1 are elevated in endotoxemia, little is known about the myocardial expression of the ET system in…”
    Get full text
    Journal Article
  13. 13

    Receptor-mediated effects of endothelin on the L-type Ca++ current in ventricular cardiomyocytes by Kelso, E J, Spiers, J P, McDermott, B J, Scholfield, C N, Silke, B

    “…The purpose of this study was to establish whether specific receptor subtypes are responsible for mediating the effects of endothelin-1 (ET-1) and endothelin-3…”
    Get more information
    Journal Article
  14. 14

    Characterisation of a Cellular Model of Cardiomyopathy, in the Rabbit, Produced by Chronic Administration of the Anthracycline, Epirubicin by Kelso, Elizabeth J., Geraghty, Robert F., McDermott, Barbara J., Cameron, C.H.S., Nicholls, D.Paul, Silke, Bernard

    “…The objective of this study was to assess the structural, mechanical and electrophysiological changes associated with chronic administration of epirubicin…”
    Get full text
    Journal Article
  15. 15

    Economic evaluation of the use of nadroparin calcium in the prophylaxis of deep vein thrombosis and pulmonary embolism in surgical patients in Italy by Lloyd, A, Aitken, J A, Hoffmeyer, U K, Kelso, E J, Wakerly, E C, Barber, N D

    Published in PharmacoEconomics (01-10-1997)
    “…The objective of this study was to compare the costs, from the perspective of the payer, of using nadroparin calcium, a low-molecular-weight heparin, instead…”
    Get full text
    Journal Article
  16. 16

    Mechanical effects of ET-1 in cardiomyocytes isolated from normal and heart-failed rabbits by Kelso, E J, Geraghty, R F, McDermott, B J, Trimble, E R, Nicholls, D P, Silke, B

    Published in Molecular and cellular biochemistry (12-04-1996)
    “…Endothelin (ET-1) is found at elevated concentrations in the plasma of patients with heart failure and in animal models of cardiomyopathy. The peptide is a…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy by Cullen, J P, Bell, D, Kelso, E J, McDermott, B J

    Published in European journal of pharmacology (13-04-2001)
    “…Increased plasma levels of endothelin-1 correlate with the severity of left ventricular hypertrophy in vivo. The aim of the study was to determine the relative…”
    Get full text
    Journal Article
  19. 19

    Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension : effects of endothelin receptor blockade by SPIERS, James P, KELSO, Elizabeth J, SIAH, Wei F, EDGE, Gillian, GUOJIE SONG, MCDERMOTT, Barbara J, HENNESSY, Martina

    Published in Journal of hypertension (01-09-2005)
    “…To determine the effects of age and dual endothelin (ET)A/ETB receptor antagonism (bosentan) on aortic matrix metalloproteinase (MMP) abundance and tissue…”
    Get full text
    Journal Article
  20. 20

    Inhibition of the acetylcholine-activated potassium current by endothelin-1 in atrial cardiomyocytes by Spiers, J. P., Kelso, E. J., McDermott, B J, Scholfield, N, Silke, B.

    Published in European heart journal (02-02-1997)
    “…Endothelin-1 (ET-1), is a 21 amino-acid peptide with potent inotropic and chronotropic actions in the heart. Relatively little is known about the underlying…”
    Get full text
    Journal Article